Glutamine

Biomarker3 papers1 finding

  • Humans3

Effects

1

Metabolic dysfunction-associated steatotic liver disease

mediatesin humans1

1 study
  1. Glutamine mediates metabolic dysfunction-associated steatotic liver disease in humans (21.42% proportion mediated).

    Humansmediating calcium and incident MASLD association13.7 years

    Circulating metabolite signatures mediating the association between minerals in domestic water and incident MASLD: a prospective cohort study · Frontiers in nutrition · 26 Aug 2026

Metabolic dysfunction-associated steatotic liver disease →

Latest

Nov 2025: 1Dec 2025: 2Jan 2026: 1Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 3Sep 2026: 8Oct 2026: 217
IUBMB LifeHumans

Plasma asparagine links to lower cardioembolic stroke risk

In Mendelian randomization, plasma free asparagine showed an odds ratio of 0.852 for cardioembolic stroke, whereas the glutamine-to-asparagine ratio…In Mendelian randomization, plasma free asparagine showed an odds ratio of 0.852 for cardioembolic stroke, whereas the glutamine-to-asparagine ratio yielded an odds ratio of 1.148.

Brain CommunicationsHumans

Brain connectivity linked to inhibition balance shifts with age

Left parietal-putamen connectivity predicted better cognitive flexibility in young adults (r = 0.41) but worse performance in older adults (r =…Left parietal-putamen connectivity predicted better cognitive flexibility in young adults (r = 0.41) but worse performance in older adults (r = -0.33).